Summary by Futu AI
PHARMACEUTICAL BIOTECHNOLOGY CO., LTD. ANNOUNCED THAT IT WILL CHANGE THE WAY THE COMPANY'S COMMUNICATIONS ARE PUBLISHED FROM 27 MARCH 2024 UNDER SECTION 2.07A OF THE NEW LISTING RULES OF THE HONG KONG STOCK EXCHANGE LIMITED. In the future, the Company will primarily send corporate communications to shareholders by e-mail and will be published publicly on company and exchange websites. If the shareholder does not provide a valid e-mail address or the address is invalid, the Company will mail a printed newsletter and attach a form requesting a valid e-mail address. Shareholders may also provide an email address at any time to the Company's Registrar or request a printed copy of the Company's communications. This is designed to support electronic communications and encourage shareholders to take an active interest in corporate communications.